tradmap

HBIO HARVARD BIOSCIENCE INC

$5.89 -3.44%

Healthcare · Laboratory Analytical Instruments

HARVARD BIOSCIENCE INC (HBIO) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $27 million. Shares last traded at $5.89, 21.4% below their 52-week high. Over the past year the stock is up 1067.3%. Net profit margin is -65.5%, below the peer median of -1.5%. Revenue declined 8.1% year over year.

Market Cap
$27M
Shares Out
4.5M
EPS (TTM)
$-14.60
P/E Ratio
P/S Ratio
0.31
P/B Ratio
2.65
Dividend / Share
Dividend Yield
52-Week High
$7.50
52-Week Low
$0.38
Volume
352
Avg Vol (3m)
1,478.413

Performance

1W
-11.29%
1M
+15.93%
3M
+22.81%
6M
+734.28%
YTD
+796.17%
1Y
+1067.33%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
46.66
SMA (50)
$6.08
SMA (200)
$2.31
Price vs SMA50
-3.04%
Price vs SMA200
+155.71%
ATR (14)
$0.31

Financials

Revenue
$87M
Net Income
$-57M
Gross Margin
57.7%
Operating Margin
-56.1%
Net Margin
-65.5%
Return on Equity
-564.4%
Return on Assets
-72.8%
Current Ratio
1.99
Debt / Equity
3.60
Revenue Growth (YoY)
-8.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-0.77 2026-05-12
FY 2025 $-1.28 2026-03-13
Q3 2025 $-1.22 2025-11-06
Q2 2025 $-1.19 2025-08-11
Q1 2026 $-11.42 2026-05-12
FY 2025 $-0.28 2026-03-13

Full earnings history →

Laboratory Analytical Instruments peers

HBIO vs 14 industry peers (Laboratory Analytical Instruments), by market cap.

P/S vs peers
0.31 / 2.95 med
-90% discount
Net margin vs peers
-65.5% / -1.5% med
below median
1–14 of 14
AAgilent Technologies$35.9B27.555.1718.8%+2.23%
WATWaters Corporation$34.9B54.3211.0320.3%-0.44%
ILMNIllumina, Inc.$24.5B28.805.6419.6%+1.68%
MTDMettler Toledo$23.1B26.595.7421.6%+1.22%
RVTYRevvity$11.1B46.223.908.4%+2.23%
BRKRBruker Corp$8.7B-1049.062.53-0.2%+4.51%
BIOBio-Rad Laboratories, Inc.$7.6B10.022.9529.4%-0.80%
AVTRAvantor, Inc.$6.5B-12.321.00-8.1%+1.16%
TXG10x Genomics, Inc.$4.5B-102.516.94-6.8%+8.24%
ALMRAlamar Biosciences, Inc.$1.5B+8.56%
EYPTEyepoint, Inc.$1.1B-4.91+3.35%
CTKBCytek Biosciences, Inc.$488M-7.342.42-33.0%-4.91%
PACBPacific Biosciences Of California, Inc.$432M-0.79+3.35%
LABSTANDARD BIOTOOLS INC.$324M-4.323.79-87.8%+2.65%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.